EWS/ETS regulates the expression of the dickkopf family in ewing family tumor cells

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Miyagawa, Yoshitaka ^a   Okita, Hajime ^a   Itagaki, Mitsuko ^a   Toyoda, Masashi ^a   Katagiri, Yohko U ^a   Fujimoto, Junichiro ^a   Hata, Jun Ichi ^a   Umezawa, Akihiro ^a   Kiyokawa, Nobutaka ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DICKKOPF 1 PROTEIN; DICKKOPF 2 PROTEIN; DICKKOPF PROTEIN; GLYCOPROTEIN; RNA BINDING PROTEIN; RNA BINDING PROTEIN ETS; RNA BINDING PROTEIN EWS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CANCER INHIBITION; CARCINOGENICITY; CONTROLLED STUDY; EWING SARCOMA; EWING SARCOMA CELL LINE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; TRANSACTIVATION;

EID: 84864277344     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004634     Document Type: Article

References (58)

1. Mohinta S, Wu H, Chaurasia P, Watabe K (2007) Wnt pathway and breast cancer. Front Biosci 12: 4020-4033.
2. Reguart N, He B, Taron M, You L, Jablons DM, et al. (2005) The role of Wnt signaling in cancer and stem cells. Future Oncol 1: 787-797.
3. Segditsas S, Tomlinson I (2006) Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25: 7531-7537.
4. Polakis P (2000) Wnt signaling and cancer. Genes Dev 14: 1837-1851.
5. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, et al. (2000) AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virusmediated transfer of AXIN1. Nat Genet 24: 245-250.
6. Kawano Y, Kypta R (2003) Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116: 2627-2634.
7. Zorn AM (2001) Wnt signalling: antagonistic Dickkopfs. Curr Biol 11: R592-595.
8. Brott BK, Sokol SY (2002) Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins. Mol Cell Biol 22: 6100-6110.
9. Mao B, Wu W, Li Y, Hoppe D, Stannek P, et al. (2001) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411: 321-325.
10. Mukhopadhyay M, Shtrom S, Rodriguez-Esteban C, Chen L, Tsukui T, et al. (2001) Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev Cell 1: 423-434.
11. Grotewold L, Theil T, Ruther U (1999) Expression pattern of Dkk-1 during mouse limb development. Mech Dev 89: 151-153.
12. Adamska M, MacDonald BT, Sarmast ZH, Oliver ER, Meisler MH (2004) En1 and Wnt7a interact with Dkk1 during limb development in the mouse. Dev Biol 272: 134-144.
13. Morvan F, Boulukos K, Clement-Lacroix P, Roman Roman S, Suc-Royer I, et al. (2006) Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 21: 934-945.
14. Li J, Sarosi I, Cattley RC, Pretorius J, Asuncion F, et al. (2006) Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone 39: 754-766.
15. Niehrs C (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25: 7469-7481.
16. Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, et al. (2006) Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 25: 4116-4121.
17. Kuphal S, Lodermeyer S, Bataille F, Schuierer M, Hoang BH, et al. (2006) Expression of Dickkopf genes is strongly reduced in malignant melanoma. Oncogene 25: 5027-5036.
18. Mikheev AM, Mikheeva SA, Rostomily R, Zarbl H (2007) Dickkopf-1 activates cell death in MDA-MB435 melanoma cells. Biochem Biophys Res Commun 352: 675-680.
19. Mikheev AM, Mikheeva SA, Maxwell JP, Rivo JV, Rostomily R, et al. (2007) Dickkopf-1 mediated tumor suppression in human breast carcinoma cells. Breast Cancer Res Treat.
20. Mikheev AM, Mikheeva SA, Liu B, Cohen P, Zarbl H (2004) A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation. Carcinogenesis 25: 47-59.
21. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, et al. (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349: 2483-2494.
22. Wirths O, Waha A, Weggen S, Schirmacher P, Kuhne T, et al. (2003) Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors. Lab Invest 83: 429-434.
23. Edamura K, Nasu Y, Takaishi M, Kobayashi T, Abarzua F, et al. (2007) Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model. Cancer Gene Ther 14: 765-772.
24. Hsieh SY, Hsieh PS, Chiu CT, Chen WY (2004) Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene 23: 9183-9189.
25. Hoang BH, Kubo T, Healey JH, Yang R, Nathan SS, et al. (2004) Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res 64: 2734-2739.
26. Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y, Namba M (2000) A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 268: 20-24.
27. Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H (2005) Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 65: 4218-4227.
28. Khoury JD (2005) Ewing sarcoma family of tumors. Adv Anat Pathol 12: 212-220.
29. Fuchs B, Inwards CY, Janknecht R (2004) Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma. Clin Cancer Res 10: 1344-1353.
30. Li X, Tanaka K, Nakatani F, Matsunobu T, Sakimura R, et al. (2005) Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells. Int J Cancer 116: 385-394.
31. Takahashi A, Higashino F, Aoyagi M, Yoshida K, Itoh M, et al. (2003) EWS/ETS fusions activate telomerase in Ewing's tumors. Cancer Res 63: 8338-8344.
32. Nakatani F, Tanaka K, Sakimura R, Matsumoto Y, Matsunobu T, et al. (2003) Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein. J Biol Chem 278: 15105-15115.
33. Hahm KB, Cho K, Lee C, Im YH, Chang J, et al. (1999) Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet 23: 222-227.
34. Im YH, Kim HT, Lee C, Poulin D, Welford S, et al. (2000) EWS-FLI1, EWSERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene. Cancer Res 60: 1536-1540.
35. Miyagawa Y, Okita H, Nakaijima H, Horiuchi Y, Sato B, et al. (2008) Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells. Mol Cell Biol.
36. Yamashita J, Miyagawa Y, Sugahara R, Mon H, Mitsunobu H, et al. (2007) Molecular Cloning of Silkworm Cdc37 and its Interaction with Hsp90 Chaperone. J Insect Biotech Seric 76: 137-143.
37. Hara S, Ishii E, Tanaka S, Yokoyama J, Katsumata K, et al. (1989) A monoclonal antibody specifically reactive with Ewing's sarcoma. Br J Cancer 60: 875-879.
38. Fujii Y, Nakagawa Y, Hongo T, Igarashi Y, Naito Y, et al. (1989) [Cell line of small round cell tumor originating in the chest wall: W-ES]. Hum Cell 2: 190-191.
39. Mori T, Kiyono T, Imabayashi H, Takeda Y, Tsuchiya K, et al. (2005) Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential. Mol Cell Biol 25: 5183-5195.
40. Gilbert F, Balaban G, Moorhead P, Bianchi D, Schlesinger H (1982) Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines. Cancer Genet Cytogenet 7: 33-42.
41. Nishi Y, Akiyama K, Korf BR (1992) Characterization of N-myc amplification in a human neuroblastoma cell line by clones isolated following the phenol emulsion reassociation technique and by hexagonal field gel electrophoresis. Mamm Genome 2: 11-20.
42. Hata J, Fujita H, Ikeda E, Matsubayashi Y, Kokai Y, et al. (1989) [Differentiation of human germ cell tumor cells]. Hum Cell 2: 382-387.
43. Miyagawa Y, Lee JM, Maeda T, Koga K, Kawaguchi Y, et al. (2005) Differential expression of a Bombyx mori AHA1 homologue during spermatogenesis. Insect Mol Biol 14: 245-253.
44. Kiyokawa N, Lee EK, Karunagaran D, Lin SY, Hung MC (1997) Mitosisspecific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor. J Biol Chem 272: 18656-18665.
45. Arvand A, Denny CT (2001) Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20: 5747-5754.
46. Gregory CA, Perry AS, Reyes E, Conley A, Gunn WG, et al. (2005) Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow. J Biol Chem 280: 2309-2323.
47. Gregory CA, Singh H, Perry AS, Prockop DJ (2003) The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem 278: 28067-28078.
48. Suzuki R, Onizuka M, Kojima M, Shimada M, Fukagawa S, et al. (2007) Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia. Br J Haematol 138: 624-631.
49. Suzuki H, Toyota M, Caraway H, Gabrielson E, Ohmura T, et al. (2008) Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer 98: 1147-1156.
50. Lee J, Yoon YS, Chung JH (2008) Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines. Gynecol Oncol 109: 270-274.
51. Sato H, Suzuki H, Toyota M, Nojima M, Maruyama R, et al. (2007) Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis 28: 2459-2466.
52. Roth W, Wild-Bode C, Platten M, Grimmel C, Melkonyan HS, et al. (2000) Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene 19: 4210-4220.
53. Joesting MS, Perrin S, Elenbaas B, Fawell SE, Rubin JS, et al. (2005) Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Res 65: 10423-10430.
54. Endo Y, Beauchamp E, Woods D, Taylor WG, Toretsky JA, et al. (2008) Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3-and c-Jun N-terminal kinase-dependent mechanism. Mol Cell Biol 28: 2368-2379.
55. Horwitz EM (2004) Dkk-1-mediated expansion of adult stem cells. Trends Biotechnol 22: 386-388.
56. Riggi N, Cironi L, Provero P, Suva ML, Kaloulis K, et al. (2005) Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res 65: 11459-11468.
57. Castillero-Trejo Y, Eliazer S, Xiang L, Richardson JA, Ilaria RL Jr. (2005) Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors. Cancer Res 65: 8698-8705.
58. Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord P, et al. (2007) Mesenchymal stem cell features of Ewing tumors. Cancer Cell 11: 421-429.